Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial

To evaluate the safety and effectiveness of epigallocatechin-3-gallate (EGCG) solution treating the acute severe dermatitis in patients receiving radiotherapy. This phase I research enrolled patients with thoracic cancer receiving radiotherapy at Shandong Cancer Hospital and Institute in Shandong, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jingjing, Jia, Li, Xie, Peng, Yin, Xiaoyan, Zhu, Wanqi, Zhao, Hong, Wang, Xin, Meng, Xiangjiao, Xing, Ligang, Zhao, Hanxi, Li, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449912/
https://www.ncbi.nlm.nih.gov/pubmed/37620508
http://dx.doi.org/10.1038/s41598-023-40881-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449912/
https://www.ncbi.nlm.nih.gov/pubmed/37620508
http://dx.doi.org/10.1038/s41598-023-40881-4

Ejemplares similares